Many diabetics across the country have been prescribed a treatment by their physicians called Pulsatile Intravenous Insulin Therapy, otherwise known as “PIVIT“ Many insurance companies, and in particular the Blue Cross Blue Shield family of insurance companies, have denied insurance coverage and reimbursement to policyholders and physicians for the PIVIT treatment, claiming the treatment is “experimental” or “investigational.” Very few, if any, medical doctors today would call PIVIT experimental or investigational treatment. I am told that all doctors prescribing this treatment believe it’s medically necessary for their patients.
While it’s true the federal Medicare program, under the Center for Medicaid Services (CMS), still does not approve reimbursement for PIVIT for Medicare patients, at least one Administrative Law Judge in the State of California has ruled that the California Public Employees Retirement System (CALPERS) is required to provide coverage and reimbursement to patients and medical providers for PIVIT treatment. Lawyers in our firm are currently investigating the denial of insurance coverage and reimbursement by insurance companies for PIVIT treatment. If you or someone you know has been denied insurance coverage, reimbursement or authorization to proceed with PIVIT treatment by an insurance company, and would like more information, contact Bill Hopkins at 800-898-2034 or by email at Bill.Hopkins@BeasleyAllen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.